Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), By Region, And Segment Forecasts, 2022 - 2030

Report Overview      

The global disposable syringes market size was valued at USD 13.45 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.12% from 2022 to 2030. The growth is attributed to the growing prevalence of chronic disorders, increasing adoption of safety syringes, and a growing number of surgeries globally. For instance, according to Mölnlycke Health Care AB in 2021, 70 million surgical procedures are performed every year in Europe.

Earlier the syringes were expensive and were used to be manufactured abundantly. Hence, healthcare professionals had to reuse syringes on different patients. As a result, it was critical for all doctors/physicians to properly sterilize and sharpen the syringe after each use. Therefore, many chronic diseases began to spread in past years. Due to this demand for disposable syringes has been increased due to their several benefits over reusable syringes. Several benefits of disposable syringes are course sterilization and safety.

Since the introduction of disposable syringes, patients no longer have to rely solely on the doctors' sterilization protocols for their safety, as they are discarded after one use. As a result, there is no risk of cross-contamination. Other advantages of disposable syringes include their low cost and environmental friendliness. These factors are positively impacting sales growth. In future years, the market is predicted to expand.

The COVID-19 pandemic has had a considerable impact on all industries, On the other hand, an increase in hospitalization rates has been observed. This is likely to increase the revenue generation channel for companies in the disposable syringes market. Additionally, due to syringe shortages, global manufacturing capacity has been increased in a number of nations, including South Korea, which has doubled its syringe supply for the COVID-19 immunization campaign in 2021.

Manufacturers are focused on efficient sterilizing procedures to avoid infections among healthcare practitioners and patients in the wake of the rapidly spreading COVID-19 pandemic. As a result, companies operating in the market are focusing on improving operational performance in order to increase their global credibility. For instance, in June 2021, to support global COVID-19 immunization efforts, BD, a multinational medical technology company, announced that it has received pandemic orders for 2 billion injectable devices in syringes and needles.

This new milestone reflects assurances from governments around the world, including Australia, the UK, Canada, Brazil, Germany, France, the Philippines, India, South Africa, Spain, Saudi Arabia, and the U.S., as well as non-governmental organizations that support vaccine deployment in developing countries. These characteristics are projected to generate lucrative market growth prospects.

However, according to the World Health Organization (WHO), there will be a 2.0 billion needle deficiency by 2022. This is due to increased demand, supply-chain disruptions, and ‘syringe nationalism' that "may pose substantial hurdles in 2022. As a result, most countries throughout the world have begun to reduce security regulations and resume certain elective treatments, indicating that the market will continue to develop during the projection period.

Additionally, organizations are gaining knowledge in their end-to-end supply chains in order to reduce product prices and improve the quality and services associated with disposable syringes. Such operational ideas help organizations save money by eliminating third-party expenses. These characteristics are projected to generate lucrative market growth prospects. 

Moreover, increasing prevalence of chronic disorders such as Crohn's disease and diabetes which can be managed by self-injecting medication. For instance, as per the International Diabetes Federation 2021 report, the number of people living with diabetes are approximately 537 million adults (20-79) in 2021 to nearly 783 million by 2045. Syringes are required for the majority of diagnostic and therapeutic approaches for chronic diseases, since they play an important role during medication administration and tests, resulting in rising demand for the product.

Furthermore, major companies are focusing on producing syringes designed exclusively for chronic disease therapy in order to increase their market position. For instance, Hypak SCF PRTC glass pre-fillable syringe from BD is used to treat chronic disorders. Along with that in May 2021, BD has announced plans to spin out its Diabetes Care division as a separate, publicly-traded company ("NewCo"). BD Diabetes Care has been a major force behind the adoption of insulin syringes and other products, generating roughly 8 billion injection devices each year and supporting approximately 30 million patients.      

Along with the above factors, the need for disposable syringes in various healthcare settings is likely to increase with the growing aging population, a demographic that is more susceptible to chronic illnesses such as diabetes and other lifestyle-related disorders. In addition, according to CDC, adults aged 65 years and above are more likely to acquire heart disease, COPS, diabetes, cancer, neurological problems, and other chronic illnesses. Patients with such illnesses require emergency and nonemergency hospital services which is expected to spur the market growth in the near future.

China dominated the market with a market revenue share of 27.09% in 2021. Government initiatives to encourage the adoption of disposable medical supplies in order to prevent infections in operating rooms is the key factor responsible for growth of the market in this region. The increasing prevalence of chronic diseases and the growing geriatric population are the factors that drive the market growth in China.      

According to Front. Public Health in 2020, chronic NCDs account for about 80% of mortality in China among adults aged 60, with Ischemic Heart Disease, Stroke, Chronic Obstructive Pulmonary Disease (COPD), and Type 2 Diabetes is the most common. Additionally, market growth is being driven by continued medical infrastructure construction, as well as growing government and private sector investments to promote the usage of safer and more cost-effective healthcare solutions.

Product Insights

The safety syringes led the market and accounted for a revenue share of 64.03% in 2021. However, conventional disposable syringes have been in use from a long time, safety syringes are more preferred nowadays due to their benefits. Safety syringes also eliminate the risk of patient-to-patient transmission of infections due to which safety syringes are likely to retain its position throughout the forecast period. The safety syringes are majorly used for administering medications by utilizing specialized and standard techniques.

Every year, over 33,800 HIV infections, 315,000 hepatitis C transmissions, and 1.7 million hepatitis B infections are caused by hazardous injecting practices around the world. Unsafe practices such as multiple use of a syringe & needle without taking precautionary measures as guided by the healthcare professionals lead to needle stick injuries. In addition, conventional disposable syringes provide protection to the recipient, but do not assure the safety of patients. Such factors are anticipated to boost the segment growth.

The conventional syringes are the second leading segment and accounted for market reveue share of 35.97% in 2021. Conventional syringes are mostly made of plastic with visible graduation and are intended for single use. Some of the advantages of disposable conventional syringes are that they eliminate the risk of infections from blood-borne pathogens, such as HIV, Ebola virus, and Hepatitis B & C.

The governments in emerging countries are undertaking initiatives to increase the use of conventional disposable syringes & needles with an aim to reduce the transmission of diseases in patients; thereby, propelling the segment growth over the forecast period

Application Insights

The therapeutic injections led the market and accounted market revue share of 85.69% in 2021. Increasing awareness toward blood donations across the globe is one of the major factors driving the segment. For instance, according to the American National Red Cross in 2021, in the U.S., 13.6 million units of red blood and whole blood cells are collected each year from the country.

Injections are used in almost every medical procedure, from diagnosis to treatment High prevalence of diseases such as AIDS, tuberculosis, malaria, and dengue in the developing, as well as underdeveloped countries, lead to demand for high volume of injections as they are one of the essential requirements for diagnosis and treatment.      

The immunization injections segment is anticipated to witness the fastest growth at a CAGR of 7.43% during the forecast period. The process of vaccination is majorly a mass activity, thus, increasing the risk of transmission of blood-borne pathogens. In such cases, the multiple use of a syringe & needle needs to be avoided to prevent the risk of needle stick injuries.

In addition, the type of injections used depend on the safety, cost, and type of vaccine to be administered. Prefilled auto-disable syringes are majorly preferred, provided all the vaccines are available in a prefilled form. This prevents vaccine contamination, increases the accuracy of dose, and reduces the waste generated due to multiple vials.                                                               

Regional Insights

Asia Pacific dominated the market and accounted for market revenue share of 31.06% in 2021. Various government measures to reassure the use of single-use medical supplies to prevent infections, as well as the presence of prominent market participants in the region, are expected to help to the region's growth.

Furthermore, increase in aging population and prevalence of chronic diseases in the region coupled with high awareness regarding the safety of disposable products are likely to increase the demand for disposable syringes in this region. For instance, in March 2021, a new government order for 265 million (auto disposable) AD syringes has been placed with Hindustan Syringes & Medical Devices Ltd (HMD). in September 2021. By the end of March, HMD had finished its past orders of 177.5 million AD syringes of 0.5 ml.

The syringes are used to administer immunizations for a variety of diseases, including yellow fever, measles, and hepatitis B. The production capacity of 0.5ml syringes AD has already been doubled from 500 million to 800 million per year, with the goal of reaching 1 billion by June 2021 which is expected to spur the market growth.

The market in MEA is likely to grow at a 6.83% rate. According to U.N. children’s agency in 2021, the shortage might affect up to 2.2 billion auto-disposable syringes that spontaneously lock to prevent re-use. The looming shortfall comes as the delivery of COVID-19 vaccine doses to Africa picks up after months of delay. Due to such shortfall the demand for disposable syringe will continue to grow.

Moreover, the market is being driven by increased healthcare spending and adoption of modern healthcare facilities. The South African government, for example, budgeted 13.5% of overall government spending on healthcare program, according to UNICEF Health Budget South Africa 2017/2018. Such occurrences are projected to provide new and significant players in the MEA market with growth prospects.

Key Companies & Market Share Insights

Companies operating in the market are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings.

In addition, the market players are adopting various strategies, such as mergers & acquisitions, partnerships, product launches and innovations such as introduction of prefilled syringe products to strengthen their foothold in the market. For instance, in August 2019, Morimoto Pharmaceuticals, based in Japan, has launched a new prefilled syringe kit named Morimoto S.A.F.E. Syringe Kit (Smart Accident prevention, Fast & Easy).

As the injection preparation is completed inside an enclosed system, innovative innovations in prefilled syringe products safeguard nurses and pharmacists from exposure to dangerous substances. Key players in the market are beefing up their R&D capabilities in order to deploy safe and simple medical practices, which is expected to enhance market growth in the near future. Some prominent players in the disposable syringes market include

• MEDTRONIC (Covidien)

• Nipro Corporation

• Fresenius Kabi AG    

• Baxter International, Inc.

• B. Braun Melsungen AG

• BD

• Terumo Corporation

• Novo Nordisk

• UltiMed, Inc.

• Henke-Sass, Wolf

• Retractable Technologies

• Flextronics International Vita Needle Company    

Disposable Syringes Market Report Scope

Segments covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global disposable syringes market report based on product, application, end use and region:

• Product Outlook (Revenue USD Million,  2017 - 2030)

  • Conventional Syringes

  • Safety Syringes

    • Retractable Safety Syringes

    • Non-retractable Safety Syringes

• Application Outlook (Revenue USD Million, 2017 - 2030)

  • Immunization Injections

  • Therapeutic Injections

• End Use Outlook (Revenue USD Million; 2017 - 2030)

  • Hospital

  • Diagnostic Laboratories

  • Blood Banks

  • Pharmaceutical industry

  • Veterinary purposes

  • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE